Masaki Otagiri

Q: What Schools Are Affiliated With Masaki Otagiri

Masaki Otagiri is affiliated with the following schools: Sojo University, University of Tokyo, University of Florida, Kumamoto University, Institute of Science Tokyo, Kyoto University

Masaki Otagiri's AcademicInfluence.com Rankings

Masaki Otagiri

Computer Science

#4754

World Rank

#5019

Historical Rank

Computational Linguistics

#519

World Rank

#527

Historical Rank

Machine Learning

#1035

World Rank

#1051

Historical Rank

Artificial Intelligence

#1262

World Rank

#1286

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Masaki Otagiri's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Masaki Otagiri Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masaki Otagiri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Structural basis of the drug-binding specificity of human serum albumin. (2005) (1510)
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. (2002) (756)
Albumin-drug interaction and its clinical implication. (2013) (322)
Cyclodextrins in drug carrier systems. (1987) (295)
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin (2002) (275)
p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. (2013) (255)
Species Differences of Serum Albumins: I. Drug Binding Sites (1997) (240)
Characterization of site I on human serum albumin: concept about the structure of a drug binding site. (1996) (240)
Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. (2000) (218)
Characterization of uremic toxin transport by organic anion transporters in the kidney. (2004) (218)
A molecular functional study on the interactions of drugs with plasma proteins. (2005) (196)
Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain (2002) (194)
Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods. (1993) (193)
Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase (1982) (183)
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. (1982) (173)
Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation (1993) (171)
Redox properties of serum albumin. (2013) (162)
Nitrosothiol Formation Catalyzed by Ceruloplasmin (1999) (151)
Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases (2014) (149)
Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. (1997) (148)
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. (2003) (146)
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. (2002) (135)
Effect of Oxidative Stress on the Structure and Function of Human Serum Albumin (2001) (131)
Antioxidant properties of some different molecular weight chitosans. (2009) (128)
Esterase-Like Activity of Serum Albumin: Characterization of Its Structural Chemistry Using p-Nitrophenyl Esters as Substrates (2004) (122)
Characterization of binding site of uremic toxins on human serum albumin. (1995) (119)
The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. (2005) (117)
An Oral Adsorbent, AST-120 Protects Against the Progression of Oxidative Stress by Reducing the Accumulation of Indoxyl Sulfate in the Systemic Circulation in Renal Failure (2007) (107)
Functional Characterization of Human Proton-Coupled Folate Transporter/Heme Carrier Protein 1 Heterologously Expressed in Mammalian Cells as a Folate Transporter (2007) (106)
Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. (2004) (101)
Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. (2008) (101)
Stereoselective binding of human serum albumin. (2006) (100)
Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 (2016) (100)
Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer. (2017) (96)
Update on the pharmacokinetics and redox properties of protein-bound uremic toxins. (2011) (93)
Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunction (2017) (92)
Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexation (1983) (89)
Species Differences of Serum Albumins: III. Analysis of Structural Characteristics and Ligand Binding Properties During N-B Transitions (1998) (89)
Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies. (2018) (88)
Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans (1991) (88)
Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney. (2011) (86)
Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. (2006) (83)
Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. (1999) (83)
Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation. (1983) (81)
Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent. (1997) (79)
Probing the cysteine 34 residue in human serum albumin using fluorescence techniques. (1997) (79)
The Controlled Release of Prednisolone Using Alginate Gel (1994) (79)
Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. (1999) (78)
Renal Clearance of Endogenous Hippurate Correlates with Expression Levels of Renal Organic Anion Transporters in Uremic Rats (2005) (75)
Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier (2004) (75)
Molecular Cloning and Functional Analyses of OAT1 and OAT3 from Cynomolgus Monkey Kidney (2005) (74)
Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress. (2004) (73)
Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan. (2009) (73)
The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). (2006) (72)
Interaction Mechanism Between Indoxyl Sulfate, a Typical Uremic Toxin Bound to Site II, and Ligands Bound to Site I of Human Serum Albumin (2001) (71)
Interaction between Two Sulfate-Conjugated Uremic Toxins, p-Cresyl Sulfate and Indoxyl Sulfate, during Binding with Human Serum Albumin (2012) (69)
Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. (2002) (69)
Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human α1-Acid Glycoprotein Genetic Variants, the A and F1*S Forms* (2011) (68)
Species Differences of Serum Albumins: II. Chemical and Thermal Stability (1998) (68)
How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin? (2002) (68)
Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. (1997) (64)
CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. (2008) (63)
Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. (2001) (62)
Antioxidant properties of high molecular weight dietary chitosan in vitro and in vivo (2011) (62)
Antioxidant protection of human serum albumin by chitosan. (2008) (60)
Enhancement of Oral Bioavailability of Spironolactone by β- and γ-Cyclodextrin Complexations (1983) (60)
Inclusion complexes of beta-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution. (1975) (57)
Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. (1993) (57)
p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress (2014) (57)
In Vitro and in Vivo Properties of Recombinant Human Serum Albumin from Pichia Pastoris Purified by a Method of Short Processing Time (2001) (57)
Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity. (2014) (56)
Characterization of Drug Binding Sites on α1-Acid Glycoprotein (1990) (56)
S-Nitrosylation of Human Variant Albumin Liprizzi (R410C) Confers Potent Antibacterial and Cytoprotective Properties (2007) (56)
Biopharmaceutics: Cytotoxicity of Absorption Enhancers in Caco‐2 Cell Monolayers (1998) (55)
Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants (2012) (53)
Study of interaction of carprofen and its enantiomers with human serum albumin--II. Stereoselective site-to-site displacement of carprofen by ibuprofen. (1993) (53)
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. (2005) (53)
Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers. (1998) (53)
Involvement of organic anion transporters in the efflux of uremic toxins across the blood–brain barrier (2006) (52)
Pharmacokinetic Study of Enclosed Hemoglobin and Outer Lipid Component after the Administration of Hemoglobin Vesicles as an Artificial Oxygen Carrier (2009) (52)
Differential Contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in Vivo Renal Uptake of Uremic Toxins in Rats (2005) (52)
Conformation of permethylated cyclodextrins and the host-guest geometry of their inclusion complexes (1984) (51)
Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. (2010) (50)
Pharmaceutically important pre- and posttranslational modifications on human serum albumin. (2009) (50)
Oxidation of Arg-410 promotes the elimination of human serum albumin. (2006) (49)
Hemoglobin Vesicles, Polyethylene Glycol (PEG)ylated Liposomes Developed as a Red Blood Cell Substitute, Do Not Induce the Accelerated Blood Clearance Phenomenon in Mice (2009) (49)
Enhancement of Dissolution Rates of Several Drugs by Low-Molecular Chitosan and Alginate (1990) (49)
Antioxidant effect of bovine serum albumin on membrane lipid peroxidation induced by iron chelate and superoxide. (2005) (49)
Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. (1993) (49)
Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. (2010) (49)
Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases. (2017) (48)
Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications. (2012) (48)
Inclusion complexation of barbiturates with beta-cyclodextrin in aqueous solution. I. Spectroscopic study on the mode of interaction. (1976) (47)
The Structure of the Cyclodextrin Complex. X. Crystal Structure of α-Cyclodextrin-Benzaldehyde (1 : 1) Complex Hexahyderate (1981) (47)
Inclusion complexes of beta-cyclodextrin with antiinflammatory drugs fenamates in aqueous solution. (1975) (46)
Improvement in the percutaneous absorption of beclomethasone dipropionate by γ‐cyclodextrin complexation (1985) (46)
Characterization of ligand binding sites on the alpha1-acid glycoprotein in humans, bovines and dogs. (2002) (45)
Recombinant Human Serum Albumin Dimer has High Blood Circulation Activity and Low Vascular Permeability in Comparison with Native Human Serum Albumin (2006) (45)
S-Nitrosylated Human Serum Albumin-mediated Cytoprotective Activity Is Enhanced by Fatty Acid Binding* (2008) (45)
Functional Analysis of Recombinant Human Serum Albumin Domains for Pharmaceutical Applications (2004) (45)
Controlled-release preparation of indomethacin using calcium alginate gel. (1993) (45)
Oxidation and Carboxy Methyl Lysine-Modification of Albumin: Possible Involvement in the Progression of Oxidative Stress in Hemodialysis Patients (2005) (45)
Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble β-cyclodextrin-epichlorohydrin polymer (1985) (44)
The Structure of the Cyclodextrin Complex. XVI. Crystal Structure of Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin-p-Iodophenol (1 : 1) Complex Tetrahydrate (1983) (44)
S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects. (2012) (44)
Interaction Between Two Dicarboxylate Endogenous Substances, Bilirubin and an Uremic Toxin, 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid, on Human Serum Albumin (1999) (44)
Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins. (1990) (44)
The Structure of the Cyclodextrin Complex. XIX. Crystal Structures of Hexakis(2,3,6-tri-O-methyl)-α-cyclodextrin Complexes with (S)- and (R)-Mandelic Acid. Chiral Recognition through the Induced-Fit Conformational Change of the Macrocyclic Ring (1987) (43)
A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy. (2013) (43)
Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin (2015) (43)
S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes. (2015) (43)
Enzymatic hydrolysis of the horn and hoof of cow and buffalo (1995) (43)
Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. (1996) (42)
Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. (2017) (42)
Validation of the Chloramine-T Induced Oxidation of Human Serum Albumin as a Model for Oxidative Damage in Vivo (2003) (42)
Effect of Olmesartan on Oxidative Stress in Hemodialysis Patients (2007) (41)
Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. (1998) (41)
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin. (1985) (41)
In Vitro and In Vivo Evaluation of the Enhancing Activity of Glycyrrhizin on the Intestinal Absorption of Drugs (2004) (40)
Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. (2008) (40)
Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury (2015) (40)
Safety Evaluation of Hemoglobin-Albumin Cluster “HemoAct” as a Red Blood Cell Substitute (2015) (40)
[Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl]. (1981) (40)
Preparation and evaluation of a controlled-release formulation of nifedipine using alginate gel beads. (1993) (40)
The Structure of the Cyclodextrin Complex. XV. Crystal Structure of Hexakis(2,3,6-tri-O-methyl)-α-cyclodextrin–p-Nitrophenol (1 : 1) Complex Monohydrate (1982) (40)
Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model. (2009) (39)
Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. (1999) (39)
Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques. (1989) (39)
A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. (2012) (39)
A comparative study of the interaction of warfarin with human α1‐acid glycoprotein and human albumin (1987) (39)
The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. (2007) (39)
Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography. (2001) (38)
Simultaneous Use of Sodium Deoxycholate and Dipotassium Glycyrrhizinate Enhances the Cellular Transport of Poorly Absorbed Compounds Across Caco‐2 Cell Monolayers (1999) (38)
[Study on binding of drug to serum protein]. (2009) (38)
Effects of cyclodextrins on chlorpromazine‐induced haemolysis and central nervous system responses (1981) (38)
Charcoal hemoperfusion in the treatment of phenytoin overdose. (2000) (37)
Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier. (2004) (37)
Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin (2014) (37)
Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model (2015) (37)
The Structure of the Cyclodextrin Complex. XVIII. Crystal Structure of β-Cyclodextrin–Benzyl Alcohol (1:1) Complex Pentahydrate (1985) (36)
Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants. (2015) (36)
Inclusion Complexation of β-Cyclodextrin with Some Sulfonamides in Aqueous Solution (1978) (36)
α1-Acid Glycoprotein Up-regulates CD163 via TLR4/CD14 Protein Pathway (2012) (36)
Inclusion complexes of cinnamic acids with cyclodextrins. Mode of inclusion in aqueous solution. (1975) (36)
Albumin fusion of thioredoxin--the production and evaluation of its biological activity for potential therapeutic applications. (2010) (36)
Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. (2008) (35)
Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. (2005) (35)
Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. (2004) (35)
Alleviation of prochlorperazine-induced primary irritation of skin by cyclodextrin complexation. (1982) (35)
Evidence for the Involvement of a Pulmonary First-Pass Effect via Carboxylesterase in the Disposition of a Propranolol Ester Derivative after Intravenous Administration (2003) (35)
Design and Evaluation of S-Nitrosylated Human Serum Albumin as a Novel Anticancer Drug (2008) (34)
Hypochlorous acid generates Nε-(carboxymethyl)lysine from Amadori products (2007) (34)
Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma. (1999) (34)
Vitamin D Receptor Activator Reduces Oxidative Stress in Hemodialysis Patients With Secondary Hyperparathyroidism (2011) (34)
Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury. (2011) (34)
Improvement of oral bioavailability of prednisolone by beta-cyclodextrin complexation in humans. (1983) (34)
Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. (2000) (34)
The uremic solute indoxyl sulfate acts as an antioxidant against superoxide anion radicals under normal‐physiological conditions (2010) (34)
Effects of Uremic Serum and Uremic Toxins on Hepatic Uptake of Digoxin (2008) (33)
Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation. (1983) (33)
HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES (2005) (33)
Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach. (2010) (33)
Effects of chitosan on oxidative stress and related factors in hemodialysis patients. (2014) (32)
Inhibitory effects of uraemic toxins 3‐indoxyl sulfate and p‐cresol on losartan metabolism in vitro (2010) (32)
Retention capacity of topical imidazole antifungal agents in the skin (1998) (32)
Evaluation of Stereoselective Transdermal Transport and Concurrent Cutaneous Hydrolysis of Several Ester Prodrugs of Propranolol: Mechanism of Stereoselective Permeation (1996) (32)
Stereoselective hydrolysis and penetration of propranolol prodrugs: in vitro evaluation using hairless mouse skin. (1995) (32)
Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis. (2014) (31)
Decreased Bilirubin-Binding Capacity in Uremic Serum Caused by an Accumulation of Furan Dicarboxylic Acid (2000) (31)
An In‐vitro and In‐vivo Correlative Approach to the Evaluation of Ester Prodrugs to Improve Oral Delivery of Propranolol (1993) (31)
Covalent Binding Between Bucillamine Derivatives and Human Serum Albumin (1996) (31)
Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin (2017) (30)
3ircular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen (2000) (30)
Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core. (2018) (30)
Effects of β- and γ-Cyclodextrins on Release of Betamethasone from Ointment Bases (1984) (30)
Carbon monoxide-bound hemoglobin vesicles ameliorate multiorgan injuries induced by severe acute pancreatitis in mice by their anti-inflammatory and antioxidant properties (2016) (29)
Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patients (2016) (29)
Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C. (2002) (29)
Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics. (2010) (29)
CRYSTAL AND MOLECULAR STRUCTURE OF 2 : 2 (±) FLURBIPROFEN-β-CYCLODEXTRIN COMPLEX (1983) (29)
The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats. (2010) (29)
Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression (2013) (29)
Cloning, expression and tissue distribution of a tetrameric form of pig carbonyl reductase. (2003) (29)
Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity (2018) (28)
Species Differences in Stereoselective Hydrolase Activity in Intestinal Mucosa (1998) (28)
Nitrosylated human serum albumin (SNO-HSA) induces apoptosis in tumor cells. (2010) (28)
Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis. (2016) (28)
In Vivo Kinetic Analysis of Covalent Binding Between N-Acetyl-L-Cysteine and Plasma Protein Through the Formation of Mixed Disulfide in Rats (2002) (28)
BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME (2005) (28)
Molecular Aspects of Human Alpha-1 Acid Glycoprotein — Structure and Function (2013) (27)
Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma. (1997) (27)
The interaction of some coumarin anticoagulants with beta-cyclodextrin in phosphate buffers. (1978) (27)
Inclusion Complexation of Prostaglandin F2α with γ-Cyclodextrin in Solution and Solid Phases (1984) (27)
Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment. (2015) (27)
Updates on contemporary protein binding techniques. (2009) (27)
Kinetic analysis of the covalent binding of captopril to human serum albumin. (1997) (27)
Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin. (2001) (27)
Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid. (2005) (27)
Kinetic studies of covalent binding between N-acetyl-L-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column. (2004) (27)
Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats (2003) (27)
New fluorescence probes for drug-albumin interaction studies. (1982) (27)
CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. (2005) (26)
Structural and drug-binding properties of α1-acid glycoprotein in reverse micelles (2002) (26)
Comparative study of interaction mode of diazepines with human serum albumin and alpha 1-acid glycoprotein. (1992) (26)
Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexation. (1988) (26)
Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation. (2007) (26)
An oral absorbent, surface-deacetylated chitin nano-fiber ameliorates renal injury and oxidative stress in 5/6 nephrectomized rats. (2017) (26)
Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations. (2015) (25)
Crystal structures of heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin complexes with (R)- and (S)-Flurbiprofen (1988) (25)
Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin. (2007) (25)
New Insight Into the Redox Properties of Uremic Solute Indoxyl Sulfate as a Pro‐ and Anti‐Oxidant (2011) (25)
Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients. (2011) (25)
Characterization of region Ic in site I on human serum albumin. Microenvironmental analysis using fluorescence spectroscopy. (1994) (25)
Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure (2018) (25)
Calcium ion binding to clinically relevant chemical modifications of human serum albumin. (1995) (25)
Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation. (1981) (25)
Effects of Cyclodextrins on the Hydrolysis of Prostacyclin and Its Methyl Ester in Aqueous Solution (1981) (25)
Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation. (2007) (25)
Investigation of the Interaction Mode of Phenothiazine Neuroleptics with α1‐Acid Glycoprotein (1992) (24)
Pharmaceutical evaluation of ibuprofen fast-absorbed syrup containing low-molecular-weight gelatin. (1992) (24)
Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury (2015) (24)
Usefulness of Antibodies for Evaluating the Biological Significance of AGEs (2008) (24)
Some fluorescent investigations of the interaction between the enantiomers of warfarin and human serum albumin (1979) (24)
Carbon monoxide-bound red blood cell resuscitation ameliorates hepatic injury induced by massive hemorrhage and red blood cell resuscitation via hepatic cytochrome P450 protection in hemorrhagic shock rats. (2014) (24)
Mode of Interaction of Loop Diuretics with Human Serum Albumin and Characterization of Binding Site (1996) (24)
Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide. (1998) (24)
Stabilization of isosorbide 5-mononitrate in solid state by β-cyclodextrin complexation (1985) (24)
Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives. (2018) (24)
advanced oxidation protein products (2008) (23)
Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications. (2016) (23)
Improvement of dissolution characteristics and chemical stability of prostaglandin E1 by .GAMMA.-cyclodextrin complexation. (1984) (23)
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers (2017) (23)
Albumin fusion prolongs the antioxidant and anti-inflammatory activities of thioredoxin in mice with acetaminophen-induced hepatitis. (2014) (23)
Effects of fatty acids on serum binding between furosemide and valproic acid. (1998) (23)
A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis (2017) (23)
Protective effects of cyclodextrins on drug-induced hemolysis in vitro. (1981) (23)
A Simple and Rapid Fluorometric Determination Method of α1-Acid Glycoprotein in Serum Using Quinaldine Red (1994) (23)
Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: pharmacological activity and cell-lubricating function. (1993) (23)
Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats. (2009) (22)
Interactions of Aldosterone Antagonist Diuretics with Human Serum Proteins (1997) (22)
Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models (2020) (22)
Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates. (1997) (22)
Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide (2015) (22)
Improvement in percutaneous absorption of prednisolone by β- and γ-cyclodextrin complexations (1987) (22)
Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury (2016) (22)
Kinetic Analysis of Covalent Binding Between N-Acetyl-L-Cysteine and Albumin Through the Formation of Mixed Disulfides in Human and Rat Serum in Vitro (2002) (22)
Biological characteristics of two lysines on human serum albumin in the high‐affinity binding of 4Z,15Z‐bilirubin‐IXα revealed by phage display (2011) (21)
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models. (2012) (21)
Therapeutic Impact of Human Serum Albumin–Thioredoxin Fusion Protein on Influenza Virus-Induced Lung Injury Mice (2014) (21)
Use of Photoaffinity Labeling and Site-directed Mutagenesis for Identification of the Key Residue Responsible for Extraordinarily High Affinity Binding of UCN-01 in Human α1-Acid Glycoprotein* (2005) (21)
Design and tuning of a cell‐penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery (2018) (21)
Quantitative determination of polysulfide in albumins, plasma proteins and biological fluid samples using a novel combined assays approach. (2017) (21)
Effects of cyclodextrins on the acid hydrolysis of digoxin (1982) (20)
Comparative study on inclusion complexations of antiinflammatory drug flurbiprofen with β-cyclodextrin and methylated β-cyclodextrins (1984) (20)
Spectroscopic study of the interaction of coumarin anticoagulant drugs with polyvinylpyrrolidone. (1989) (20)
Binding characteristics of coumarin anticoagulants to human α1-acid glycoprotein and human serum albumin (1990) (20)
Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties. (2000) (20)
How Tightly Can a Drug Be Bound to a Protein and Still Be Removable by Charcoal Hemoperfusion in Overdose Cases? (2005) (20)
Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet. (2000) (20)
Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver. (1997) (20)
Parathyroid hormone contributes to the down‐regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF‐&kgr;B signaling pathway in secondary hyperparathyroidism (2017) (20)
Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment. (2010) (20)
CONSTRUCTION OF EXPRESSION SYSTEM FOR HUMAN α1-ACID GLYCOPROTEIN IN PICHIA PASTORIS AND EVALUATION OF ITS DRUG-BINDING PROPERTIES (2004) (20)
Further Evaluation of a New Penetration Enhancer, HPE‐101 (1993) (20)
Effect of genetic variation on the thermal stability of human serum albumin. (2005) (20)
Enhancement of the dissolution rates of poorly water-soluble drugs by water-soluble gelatin. (1989) (19)
The Structure of the Cyclodextrin Complex. XI. Crystal Structure of Hexakis(2,3,6-tri-O-methyl)-α-cyclodextrin–p-Iodoaniline Monohydrate (1982) (19)
Improvement of thermal and photochemical stability of benzaldehyde by cyclodextrin complexation (1983) (19)
Purification and catalytic properties of a tetrameric carbonyl reductase from rabbit heart. (1999) (19)
Differential Effects of Methoxy Group on the Interaction of Curcuminoids with Two Major Ligand Binding Sites of Human Serum Albumin (2014) (19)
Evaluation of quinaldine red as a fluorescent probe for studies of drug-alpha 1-acid glycoprotein interaction. (1993) (19)
Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative stress conditions such as chronic kidney disease. (2016) (19)
Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding (2011) (19)
Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin. (2009) (19)
Enhancement of dissolution and absorption of mefenamic acid by egg albumin. (1991) (19)
Effect of different chemical bonds in pegylation of zinc protoporphyrin that affects drug release, intracellular uptake, and therapeutic effect in the tumor. (2015) (18)
Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products. (2007) (18)
Cellular uptake mechanisms and responses to NO transferred from mono- and poly-S-nitrosated human serum albumin (2011) (18)
Purification and properties of carbonyl reductase from rabbit kidney. (1993) (18)
X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE ABSOLUTE CONFIGURATION OF (+) FLURBIPROFEN UTILIZING β-CYCLODEXTRIN COMPLEXATION (1984) (18)
Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin (2008) (18)
Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation. (1983) (18)
Antioxidant and renoprotective activity of chitosan in nephrectomized rats. (2012) (18)
One-step preparation of S-nitrosated human serum albumin with high biological activities. (2010) (18)
[Inclusion complexation of p-hydroxybenzoic acid esters with alpha- and beta-cyclodextrins: dissolution behaviors and antimicrobial activities (author's transl)]. (1980) (18)
Preparation, Characterization, and in Vitro/in Vivo Evaluation of Paclitaxel-Bound Albumin-Encapsulated Liposomes for the Treatment of Pancreatic Cancer (2019) (17)
Characterization of benzodiazepine binding site on human alpha1-acid glycoprotein using flunitrazepam as a photolabeling agent. (2005) (17)
Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells (2018) (17)
Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A) (2005) (17)
Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique (2019) (17)
Circular dichroic investigations of the binding of salicylate and related compounds to human serum albumin. (1977) (17)
Further characterization of reversal of signs of induced cotton effects of dicumarol derivatives-alpha 1-acid glycoprotein systems by protriptyline. (1992) (17)
Kupffer cell inactivation by carbon monoxide bound to red blood cells preserves hepatic cytochrome P450 via anti-oxidant and anti-inflammatory effects exerted through the HMGB1/TLR-4 pathway during resuscitation from hemorrhagic shock. (2015) (17)
Postnatal development, sex-related difference and hormonal regulation of acetohexamide reductase activities in rat liver and kidney. (1993) (17)
Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells (2011) (17)
Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro. (1983) (17)
Influence of egg albumin on dissolution of several drugs (1989) (17)
Stabilization of mitomycins on complexation with cyclodextrins in aqueous acidic media (1989) (16)
Decrease in Plasma Concentrations of Antiangiogenic Agent TSU-68 ((Z)-5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid) during Oral Administration Twice a Day to Rats (2007) (16)
Evaluation of a new penetration enhancer 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101). (1992) (16)
[Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation]. (1984) (16)
Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy (1980) (16)
Improvements to some pharmaceutical properties of flurbiprofen by beta- and gamma-cyclodextrin complexations. (1983) (16)
In vitro identification of the human cytochrome P-450 enzymes involved in the N-demethylation of azelastine. (1999) (16)
The structure of the Cyclodextrin Complex. XIV. Crystal Structure of Hexakis(2,3,6-tri-O-methyl)-α-cyclodextrin–Benzaldehyde (1 : 1) Complex (1982) (16)
Stereoselective reduction of acetohexamide in cytosol of rabbit liver. (1989) (16)
Investigation of pathways of advanced glycation end-products accumulation in macrophages. (2007) (16)
Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions. (2017) (16)
Thioredoxin-albumin fusion protein prevents copper enhanced zinc-induced neurotoxicity via its antioxidative activity. (2018) (16)
Albumin as a nitric oxide-traffic protein: characterization, biochemistry and possible future therapeutic applications. (2009) (16)
Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. (1998) (15)
Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat. (1996) (15)
Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solutions (1991) (15)
A Fourteen-Day Observation and Pharmacokinetic Evaluation after a Massive Intravenous Infusion of Hemoglobin-Vesicles (Artificial Oxygen Carriers) in Cynomolgus Monkeys (2012) (15)
Serum Albumin, Lipid and Drug Binding. (2020) (15)
Covalent Binding of a Bucillamine Derivative with Albumin in Sera from Healthy Subjects and Patients with Various Diseases (1997) (15)
Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes. (2001) (15)
Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation. (1982) (15)
Cross‐linked human serum albumin dimer has the potential for use as a plasma‐retaining agent for the fatty acid‐conjugated antidiabetic drugs (2015) (15)
Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment. (2013) (15)
INDUCED CIRCULAR DICHROISM OF RACEMIC METHYLCYCLOHEXANONES INCLUDED IN β-CYCLODEXTRIN (1974) (15)
Benzbromarone Attenuates Oxidative Stress in Angiotensin II- and Salt-Induced Hypertensive Model Rats (2018) (15)
A site-directed mutagenesis study of drug-binding selectivity in genetic variants of human alpha(1)-acid glycoprotein. (2009) (15)
Alteration in the pharmacokinetics of hemoglobin-vesicles in a rat model of chronic liver cirrhosis is associated with Kupffer cell phagocyte activity. (2011) (15)
Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivo. (1984) (14)
Involvement of disulfide bonds and histidine 172 in a unique β‐sheet to α‐helix transition of α1‐acid glycoprotein at the biomembrane interface (2006) (14)
Liposome-encapsulated hemoglobin (hemoglobin-vesicle) is not transferred from mother to fetus at the late stage of pregnancy in the rat model. (2012) (14)
Identification of Human Liver Cytochrome P450 Isoforms Involved in Autoinduced Metabolism of the Antiangiogenic Agent (Z)-5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic Acid (TSU-68) (2008) (14)
Photoaffinity Labeling of Plasma Proteins (2013) (14)
When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications (2021) (14)
Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV. (2020) (14)
Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape. (2019) (14)
Tryptophan Residues Play an Important Role in the Extraordinarily High Affinity Binding Interaction of UCN-01 to Human α-1-Acid Glycoprotein (2004) (14)
Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state. (1985) (14)
In vivo drug delivery efficiency of albumin-encapsulated liposomes as hydrophobic drug carriers (2018) (14)
Improvement of Absorption Rate of Indomethacin and Reduction of Stomach Irritation by Alginate Dispersions (1991) (14)
Dual Therapeutic Effects of an Albumin-Based Nitric Oxide Donor on 2 Experimental Models of Chronic Kidney Disease. (2017) (14)
Comparison of the pharmacological and biological properties of HPMA copolymer‐pirarubicin conjugates: A single‐chain copolymer conjugate and its biodegradable tandem‐diblock copolymer conjugate (2017) (14)
Superior Plasma Retention of a Cross-Linked Human Serum Albumin Dimer in Nephrotic Rats as a New Type of Plasma Expander (2010) (14)
Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicine. (2014) (13)
Improvement of oral bioavailability of fenbufen by cyclodextrin complexations. (1992) (13)
Preparation and antioxidant activity of PEGylated chitosans with different particle sizes. (2014) (13)
Comparative Study on Inclusion Complexation of Maltosyl‐β‐cyclodextrin, Heptakis(2,6‐di‐O‐methyl)‐β‐cyclodextrin and β‐Cyclodextrin with Fucosterol in Aqueous and Solid State (1993) (13)
7-Alkylaminocoumarin-4-acetic acids as fluorescent probe for studies of drug-binding sites on human serum albumin. (1991) (13)
Effects of tricyclic drug on induced circular dichroism spectra of dicumarol bound to alpha 1-acid glycoprotein. (1991) (13)
Poly-S-Nitrosated Albumin as a Safe and Effective Multifunctional Antitumor Agent: Characterization, Biochemistry and Possible Future Therapeutic Applications (2013) (13)
The role of N-acetyl-methioninate as a new stabilizer for albumin products. (2007) (13)
Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate (2018) (13)
Receptor-mediated uptake of human alpha1-acid glycoprotein into liver parenchymal cells in mice. (2010) (13)
Mixed-ligand Complexes of Copper(II). I. An ESR Study of Coordination Bonding (1971) (13)
Permeability of 5-fluorouracil and its prodrugs in Caco-2 cell monolayers: evidence for shift from paracellular to transcellular transport by prodrug formation (2009) (13)
Interaction mode of dicumarol and its derivatives with human serum albumin, alpha 1-acid glycoprotein and asialo alpha 1-acid glycoprotein. (1992) (13)
Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemia. (2016) (13)
Carbon Monoxide–Bound Red Blood Cells Protect Red Blood Cell Transfusion-Induced Hepatic Cytochrome P450 Impairment in Hemorrhagic-Shock Rats (2013) (13)
Immunological Detection of Nω‐(Carboxymethyl)arginine by a Specific Antibody (2008) (13)
Improving the pharmacokinetic and pharmacodynamic properties of a drug by chemical conversion to a chimera drug. (1999) (13)
Crystal structures of permethylated .BETA.-cyclodextrin complexes with R-(-)- and S-(+)-flurbiprofen. (1984) (13)
Complex formation of hexakis(2,3,6-tri-O-methyl)-α-cyclodextrin with substituted benzenes in aqueous solution (1988) (13)
The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin. (2017) (13)
Drug Binding to α1-Acid Glycoprotein Studied by Circular Dichroism (2004) (12)
Further studies on 20beta-hydroxysteroid dehydrogenase with carbonyl reductase-like activity present in liver microsomes of male rats. (2000) (12)
Cooperative effect of hydrophobic and electrostatic forces on alcohol‐induced α‐helix formation of α1‐acid glycoprotein (2005) (12)
Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy (2011) (12)
Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease. (2017) (12)
1H-NMR SPECTROSCOPIC EVIDENCE ON CHIRAL DISCRIMINATION OF dl-PIRPROFEN BY β-CYCLODEXTRIN COMPLEXATION (1985) (12)
Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. (2012) (12)
Potential Use of Biological Proteins for Liver Failure Therapy (2015) (12)
Polythiol-Containing, Recombinant Mannosylated-Albumin Is a Superior CD68+/CD206+ Kupffer Cell–Targeted Nanoantioxidant for Treatment of Two Acute Hepatitis Models (2015) (12)
Characterization of site I of human serum albumin using spectroscopic analyses: locational relations between regions Ib and Ic of site I. (2004) (12)
Characterization of drug binding sites on alpha 1-acid glycoprotein. (1990) (12)
Effects of α1-Acid Glycoprotein on Erythrocyte Deformability and Membrane Stabilization (2003) (12)
Circular dichroism study on inclusion complexes of β-cyclodextrin with anti-inflammatory fanamates (1974) (12)
Tyrosine411 and Arginine410 of Human Serum Albumin Play an Important Role in the Binding of Sodium 4-Phenylbutyrate to Site II. (2016) (12)
Parathyroidectomy Markedly Reduces Oxidative Stress in a Patient with Primary Hyperparathyroidism (2011) (12)
Carbon Monoxide Rescues the Developmental Lethality of Experimental Rat Models of Rhabdomyolysis-Induced Acute Kidney Injury (2020) (12)
Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury (2015) (12)
Characterization of hepatic cellular uptake of α1-acid glycoprotein (AGP), part 2: involvement of hemoglobin β-chain on plasma membranes in the uptake of human AGP by liver parenchymal cells. (2012) (11)
S‐nitrosated α‐1‐acid glycoprotein kills drug‐resistant bacteria and aids survival in sepsis (2013) (11)
Establishment of a model of acetaminophen-induced hepatotoxicity in different weekly-aged ICR mice (2015) (11)
20β-Hydroxysteroid Dehydrogenase Catalyzes Ketone-Reduction of Acetohexamide, an Oral Antidiabetic Drug, in Liver Microsomes of Adult Male Rats (1998) (11)
Time-dependent induction of rat hepatic CYP1A1 and CYP1A2 expression after single-dose administration of the anti-angiogenic agent TSU-68. (2008) (11)
Alleviation of the chlorpromazine-induced muscular tissue damage by β-cyclodextrin complexation (1984) (11)
Enantiospecific disposition of pranoprofen in beagle dogs and rats. (2003) (11)
An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages. (2011) (11)
Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities (2019) (11)
Study on the binding of dicumarol to alpha 1-acid glycoprotein using circular dichroism spectroscopy. (1988) (11)
Repeated Injection of High Doses of Hemoglobin-Encapsulated Liposomes (Hemoglobin Vesicles) Induces Accelerated Blood Clearance in a Hemorrhagic Shock Rat Model (2011) (11)
Effect of pH and small inorganic ions on binding of sulfadimethoxine and sulfaphenazole to human serum albumin measured by circular dichroism. (1989) (11)
Fluid Resuscitation with Hemoglobin Vesicles Prevents Escherichia coli Growth via Complement Activation in a Hemorrhagic Shock Rat Model (2011) (10)
The New Delivery Strategy of Albumin Carrier Utilizing the Interaction with Albumin Receptors. (2022) (10)
Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface. (2007) (10)
Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection. (2015) (10)
N-acetyl-l-methionine is a superior protectant of human serum albumin against photo-oxidation and reactive oxygen species compared to N-acetyl-L-tryptophan. (2014) (10)
Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice (2020) (10)
Electrochemical oxidation of chlorpromazine-cyclodextrin inclusion complex. (1984) (10)
Photochirogenesis with mutant human serum albumins: enantiodifferentiating photocyclodimerization of 2-anthracenecarboxylate. (2013) (10)
Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute (2013) (10)
Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes. (1983) (10)
Characterization of binding sites for sulfadimethoxine and its major metabolite, N4-acetylsulfadimethoxine, on human and rabbit serum albumin. (1989) (10)
An evaluation of novel biological activity in a crude extract from Hemerocallis fulva L. var. sempervirens M. Hotta (2014) (10)
Sex difference of acetohexamide reduction in rat liver. (1987) (10)
S-guanylation of human serum albumin is a unique posttranslational modification and results in a novel class of antibacterial agents. (2012) (10)
Human serum albumin : new insights on its structural dynamics, functional impacts and pharmaceutical applications (2013) (10)
Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites (2018) (10)
Fluorescence Behavior of 7-Substituted Coumarin Derivatives by Inclusion Complexation with β-Cyclodextrin (1983) (10)
The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. (2017) (9)
Albumins with new functions and clinical applications. (2009) (9)
Activity Coefficients of Dimethyl-β-cyclodextrin in Aqueous Solutions (1986) (9)
In vitro percutaneous absorption of prednisolone derivatives based on solubility parameter (1997) (9)
CRYSTAL STRUCTURES OF PERMETHYLATED α-CYCLODEXTRIN COMPLEXES WITH L- AND D-MANDELIC ACIDS (1983) (9)
Inclusion Complexations of Indomethacin and Its Related Compounds with Cyclodextrins in Aqueous Solution (1982) (9)
Fluorescent Investigations of Binding of Phenprocoumon to α1-Acid Glycoprotein (1987) (9)
Kinetic studies on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. (1993) (9)
Stereoselective protein binding of alprenolol in the renal diseased state. (2002) (9)
Stereoselective disposition of pranoprofen, a nonsteroidal antiinflammatory drug, in rabbits. (1993) (9)
[Improvement of local irritation induced by intramuscular injection of tiamulin by cyclodextrin complexation]. (1982) (8)
Structural and drug-binding properties of alpha(1)-acid glycoprotein in reverse micelles. (2002) (8)
Characterization of a binding site of UCN-01, a novel anticancer drug on alpha-acid glycoprotein. (2000) (8)
Effect of low-molecular casein and gelatin on absorption of ibuprofen after oral and rectal administration. (1991) (8)
Erratum: Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients (Kidney International (2004) 66 (841-848)) (2004) (8)
Inhibition of rabbit heart carbonyl reductase by fatty acids. (1999) (8)
The interaction of some N-phenylanthranilic acid derivatives with cyclodextrins in phosphate buffers. (1976) (8)
[Improvement in pharmacological properties of thiopental by gamma-cyclodextrin complexation]. (1983) (8)
Microcalorimetric investigations of pharmaceutical complexes II. Drug-albumin interactions. (1978) (8)
Syntheses and properties of 3-hydroxy-4,6-dimethylpyrrolo(3,2-d)pyrimidine-5,7(4H,6H)-dione (9-hydroxy-9-deazatheophylline) derivatives. (1982) (8)
Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. (2020) (8)
An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat. (1993) (8)
Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration. (1994) (8)
Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study. (2016) (8)
N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan (2016) (8)
Reversal of Signs of Induced Cotton Effects of Dicumarol-α1-Acid Glycoprotein Systems by Phenothiazine Neuroleptics Through Ternary Complexation (1992) (8)
MODIFICATION OF SUBSTITUENT EFFECT BY CYCLODEXTRIN COMPLEXATION IN ALKALINE HYDROLYSIS OF 7-SUBSTITUTED COUMARINS (1981) (8)
Electrochemical Oxidation of Chlorpromazine Hydrochloride in Aqueous Buffer (1983) (8)
Interaction of Benzothiadiazides with Human Serum Albumin Studied by Dialysis and Spectroscopic Methods (1994) (8)
INTERACTION OF WARFARIN WITH HUMAN SERUM ALBUMIN (1980) (8)
An immunological method for the detection of captopril-protein conjugate (1998) (8)
High-performance liquid chromatography with chemiluminescence detection of penbutolol and its hydroxylated metabolite in rat plasma. (2001) (7)
A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells (2021) (7)
Mixed-ligand Complexes of Copper(II). II. A Study of Dismutation Constants (1971) (7)
Liposome-encapsulated methemoglobin as an antidote against cyanide poisoning. (2021) (7)
Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution. (1984) (7)
Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying. (2019) (7)
Improved dissolution and absorption of drugs using low molecular gelatin. (1990) (7)
Metabolic reduction of acetohexamide by rabbit tissues. (1985) (7)
Stabilization of daunorubicin and 4-demethoxydaunorubicin on complexation with octakis(2,6-di-O-methyl)-γ-cyclodextrin in acidic aqueous solution (1992) (7)
Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia. (2014) (7)
Microcalorimetric investigations of pharmaceutical complexes. I. Drugs and beta-cyclodextrin. (1978) (7)
The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier. (1996) (7)
Species Differences in the Binding of Sodium 4-Phenylbutyrate to Serum Albumin. (2017) (7)
Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System. (2020) (7)
Effect of oral multiple-dose administration of anti-inflammatory flurbiprofen chimera drug on gastric lesion, other toxicities and disposition kinetics. (1995) (7)
Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin (2000) (7)
Further Evidence Regarding the Important Role of Chlorine Atoms of Aripiprazole on Binding to the Site II Area of Human Albumin. (2019) (7)
Purification and characterization of befunolol reductase from rabbit liver. (1989) (7)
Stereoselective serum protein binding of ketoprofen in liver diseases. (1999) (7)
Use of hemoglobin for delivering exogenous carbon monoxide in medicinal applications. (2018) (7)
Strain- and sex-related differences of acetohexamide reductase activities in liver microsomes and cytosol of rats: the Wistar-Imamichi strain lacks the male-specific microsomal enzyme activity. (1995) (6)
Study of interaction of pranoprofen with human serum albumin: binding properties of enantiomers and metabolite. (1992) (6)
Construction of an expression system for human alpha(1)-acid glycoprotein in E. coli: The roles of oligosaccharide moieties in structural and functional properties. (2010) (6)
Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human 1-Acid Glycoprotein Genetic Variants , the A and F 1 * S Forms * (2011) (6)
Variation in the heats of reaction of drugs and albumin with the source and pretreatment of the albumin (1979) (6)
Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. (2013) (6)
New synthesis of 1,3-dimethyl-7-hydroxypyrrolo(3,2-d)pyrimidine-2,4(1H,3H)-diones (9-hydroxy-9-deazatheophyllines). (1981) (6)
Drug binding to alpha 1-acid glycoprotein studied by circular dichroism. (1989) (6)
Investigation of the interaction mode of phenothiazine neuroleptics with alpha 1-acid glycoprotein. (1992) (6)
Metyrapone reductase purified partially from liver microsomes of male rats: the enzyme differs from acetohexamide reductase. (1997) (6)
Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice (2021) (6)
[Improvements of some pharmaceutical properties of aralkylalcohols by cyclodextrin complexation]. (1982) (6)
Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model. (2013) (6)
FK506 (tacrolimus) increases rat alpha1-acid glycoprotein expression in liver and primary cultured hepatocytes. (2001) (6)
Influence of Molecular Structure on O2-Binding Properties and Blood Circulation of Hemoglobin‒Albumin Clusters (2016) (5)
Effect of phenylbutazone on serum protein binding of sulfadimethoxine in different animal species. (1986) (5)
Anomalous dissolution behavior of the diazepam — γ-cyclodextrin complex in polymer solutions (1984) (5)
Circular dichroic investigations into binding of sulfonamides to serum albumin (1989) (5)
Interaction of Benzbromarone with Subdomains IIIA and IB/IIA on Human Serum Albumin as the Primary and Secondary Binding Regions. (2021) (5)
Microcalorimetric investigations of drug-albumin interactions. (1984) (5)
The Effect of Metoclopramide on the Absorption and Pharmacology of Chlorpromazine in the Rat (1988) (5)
Involvement of disulfide bonds and histidine 172 in a unique beta-sheet to alpha-helix transition of alpha 1-acid glycoprotein at the biomembrane interface. (2006) (5)
Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer's disease treatment (2019) (5)
Apoptosis induction of poly-S-nitrosated human serum albumin in resistant solid tumor under hypoxia can be restored by phosphodiesterase 5 inhibition. (2017) (5)
Pharmacological advantages of conjugation of Cu, Zn-superoxide dismutase with succinylated keratin fragment: improvement of biological properties and resistance to oxidative damage. (1996) (5)
Improvement of dissolution and absorption characteristics of indomethacin by water-soluble alpha-cyclodextrin-epichlorohydrin polymer. (1987) (5)
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions (2018) (5)
Effect of phenylbutazone on serum protein binding and pharmacokinetic behavior of sulfadimethoxine in rabbits, dogs and rats. (1989) (5)
Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B. (2012) (5)
Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model. (2015) (5)
Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody. (2008) (5)
Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats. (2021) (5)
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes (2021) (5)
Assessing cytochrome P450-based drug-drug interactions with hemoglobin-vesicles, an artificial red blood cell preparation, in healthy rats. (2020) (5)
Comparative Study of Interaction Mode of Diazepines with Human Serum Albumin and a α_1-Acid Glycoprotein (1993) (5)
Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis. (2020) (5)
Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats. (1998) (4)
Metabolic reduction of acetohexamide in rat kidney: sex difference and effect of streptozotocin-induced diabetes. (1988) (4)
Characterization of the hepatic cellular uptake of α(1) -acid glycoprotein (AGP), part 1: a peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells. (2012) (4)
Effects of Cyclodextrins on the Riboflavin-Sensitized Photooxidation of Phenothiazine Derivatives (1983) (4)
Effects of alpha 1-acid glycoprotein on erythrocyte deformability and membrane stabilization. (2003) (4)
Purification and catalytic properties of a novel acetohexamide-reducing enzyme from rabbit heart. (1996) (4)
Antioxidative effect of albumin on amyloid fibril formation in transthyretin-related amyloidosis (2011) (4)
Stereoselectivity in cutaneous hydrolysis and transdermal transport of propranolol prodrug. (1997) (4)
Improvement of some pharmaceutical properties of carmoful by cycrodextrin complexation (1984) (4)
Quantitation of Meclizine Dihydrochloride in Serum by Reversed Phase Ion Pair High Performance Liquid Chromatography (1987) (4)
Simultaneous determination of a new dihydropyridine calcium antagonist (MPC-1304) and its metabolite in dog plasma by high-performance liquid chromatography with electrochemical detection. (1991) (4)
Characterization of the interaction of daptomycin with site II on human serum albumin. (2020) (4)
Chemical modification of arginine and lysine residues in coenzyme-binding domain of carbonyl reductase from rabbit kidney: indomethacin affords a significant protection against inactivation of the enzyme by phenylglyoxal. (1994) (4)
UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin. (2013) (4)
Spectroscopic studies of interactions of chondroitin sulfates with cisplatin. (2011) (4)
Nitration of indoxyl sulfate facilitates its cytotoxicity in human renal proximal tubular cells via expression of heme oxygenase-1. (2015) (4)
A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan. (2017) (4)
α1-Acid Glycoprotein Has the Potential to Serve as a Biomimetic Drug Delivery Carrier for Anti-Cancer Agents. (2019) (4)
Pharmacokinetics studies of 4′‐cyano‐2′‐deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats (2018) (4)
Stability of a cisplatin-chondroitin sulfate A complex in plasma and kidney in terms of protein binding. (2001) (4)
Long-term pharmaceutical stability of liposome-encapsulated methemoglobin as an antidote for cyanide poisoning. (2021) (4)
Effects of Oxidation of Human Serum Albumin on the Binding of Aripiprazole. (2020) (4)
Bioinspired carbon monoxide delivery using artificial blood attenuates the progression of obliterative bronchiolitis via suppression of macrophage activation by IL-17A (2021) (4)
Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin. (2021) (4)
Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases. (1984) (4)
Probenecid-induced changes in the clearance of pranoprofen enantiomers. (2003) (4)
Antioxidant and renoprotective activity of 2‐hydroxypropyl‐β‐cyclodextrin in nephrectomized rats (2016) (4)
Reduction of acetohexamide by rabbit heart cytosol. (1986) (4)
Interaction of Aripiprazole with Human α1-Acid Glycoprotein. (2019) (4)
The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors (2021) (4)
Oxidized liposomal artificial red blood cells rescue azide-poisoned mice from lethal toxidrome by recovering cytochrome c oxidase activity (2022) (4)
Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs. (1998) (3)
Up-regulation by clarithromycin of α1-acid glycoprotein expression in liver and primary cultured hepatocytes11Abbreviations: AGP, α1-acid glycoprotein; CAM, clarithromycin; DEX, dexamethasone; GR, glucocorticoid receptor; GRE, glucocorticoid response element; IL, interleukin; and PCR, polymerase cha (2001) (3)
Effect of PEGylation on the physicochemical and pharmacokinetic characteristics of bovine serum albumin-encapsulated liposome (2016) (3)
Effect of clarithromycin on alpha1-acid glycoprotein levels in normal and diabetic rats. (1998) (3)
Comparison of Pharmacokinetics between Highly and Mildly Modified AGE Proteins in Mice (2008) (3)
Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites (2019) (3)
A strategy for the immediate-release of indomethacin from a sustained-release preparation using a chitosan hydrolysate (2000) (3)
Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans. (2010) (3)
Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury (2021) (3)
Cooperative effect of hydrophobic and electrostatic forces on alcohol-induced alpha-helix formation of alpha1-acid glycoprotein. (2005) (3)
Acetohexamide reductase activities in liver microsomes and cytosol of cisplatin-treated male rats: cisplatin indirectly modulates the microsomal enzyme activity. (1996) (3)
Characterization of acetohexamide reductases purified from rabbit liver, kidney, and heart: structural requirements for substrates and inhibitors. (1997) (3)
Hormonal regulation of male-specific 20β-hydroxysteroid dehydrogenase with carbonyl reductase-like activity present in kidney microsomes of rats (2001) (3)
Evaluation of cytochrome P450-based drug metabolism in hemorrhagic shock rats that were transfused with native and an artificial red blood cell preparation, Hemoglobin-vesicles (2020) (3)
Oral pharmacokinetics and in‐vitro metabolism of metyrapone in male rats (2016) (3)
Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model. (2020) (3)
Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural–Chemical Investigation (2022) (3)
In vitro and in situ models for the prediction of in vivo absorption behavior of sulfonamides following dissolution. (1983) (3)
Crystal structures of permethylated -cyclodextrin complexes with L- and D-mandelic acids (1984) (3)
Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method. (2013) (3)
Improvment of Absorption Characteristics and Reduction of Irritation on Stomach of Flurbiprofen by complexation with Various Cyclodextrins (1987) (3)
A Topological Analysis of the Drug Binding Sites on Human Serum Albumin (2001) (3)
Mutual effect of egg albumin and fatty acids on bioavailability of dl-α-tocopherol (1997) (3)
Interaction of Barbituric Acid Derivatives with Chloral Hydrate (1975) (2)
Further studies on reductive metabolism of acetohexamide in heart. (1989) (2)
Stereoselective inhibition of carbonyl reductase from rabbit kidney by enantiomers of carprofen. (1994) (2)
Inheritance of acetohexamide reductase activities in liver microsomes and cytosol of rats. (1996) (2)
Determination of barnidipine in human serum and dog plasma by HPLC with electrochemical detection. (1995) (2)
Catalytic properties for naphthoquinones and partial primary structure of rabbit heart acetohexamide reductase. (2000) (2)
Studies on metabolic reduction of befunolol in rabbit liver and kidney. (1988) (2)
[Metabolic reduction of acetohexamide in rat liver and kidney]. (1988) (2)
Postnatal development and sex-related difference of metyrapone reductase activities in liver microsomes and cytosol of the rat. (1993) (2)
Interaction of the Fluorescent Probe 7-Anilino-4-methylcoumarin-3-acetic Acid with α-Globulin (1985) (2)
Evaluation of the topical delivery of a prednisolone derivative based upon percutaneous penetration kinetic analysis. (1998) (2)
Effects of α1-acid glycoprotein on isometric tension of mouse aorta (2003) (2)
Contribution of N4-acetylsulfadimethoxine to the interaction of sulfadimethoxine with ketoprofen in rabbits. (1987) (2)
Mechanism of inhibition of carbonyl reductase from rabbit kidney by phenylbutazone. (1995) (2)
[In vivo and in vitro serum protein binding of sulfonamides in rabbits]. (1985) (2)
[Polymorphism of 3,9-bis-(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2- c]quinoline-6-one(KCA-098), a new benzofuroquinoline derivative]. (1995) (2)
Effect of N-B transition on the microenvironment surrounding 34Cys in human serum albumin. (1997) (2)
Interaction of the fluorescent probe 7-anilino-4-methylcoumarin-3-acetic acid with alpha-globulin. (1985) (2)
20beta-hydroxysteroid dehydrogenase catalyzes ketone-reduction of acetohexamide, an oral antidiabetic drug, in liver microsomes of adult male rats. (1998) (2)
The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients (2021) (2)
Evaluation of Usefulness of Population Pharmacokinetics Analysis Results to Community Pharmacy : Effects of Smoking and Gender Difference on Olanzapine Dosages (2006) (2)
Effects of Cyclodextrins on the Hemolysis Induced with Phenothiazine Neuroleptics (1982) (2)
Novel nitric oxide donor, nitrated phenylbutyrate, induces cell death of human pancreatic cancer cells and suppresses tumor growth of cancer xenografts. (2022) (2)
Pharmacokinetic properties of a novel inosine analog, 4′-cyano-2′-deoxyinosine, after oral administration in rats (2018) (2)
Opposite effects of metoclopramide and propantheline on intestinal absorption of imipramine in rats. (1991) (2)
[Effect of aluminum ion on sulfisomidine absorption in rabbits]. (1986) (2)
The Development of a Novel, Validated, Rapid and Simple Method for the Detection of Sarcocystis fayeri in Horse Meat in the Sanitary Control Setting. (2016) (2)
Mechanism of pharmacodynamic and pharmacokinetic interactions between acetohexamide and phenylbutazone in rabbits. (1990) (2)
Species difference in the in vitro metabolic reduction of acetohexamide. (1988) (2)
Liposomal methemoglobin as a potent antidote for hydrogen sulfide poisoning. (2022) (2)
Interaction between methacycline and human serum albumin. (1984) (2)
S‐Nitrosated alpha‐1‐acid glycoprotein exhibits antibacterial activity against multidrug‐resistant bacteria strains and synergistically enhances the effect of antibiotics (2019) (2)
Characterization of urinary metabolites of a new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), in dogs. (1999) (2)
Sex-dependent pharmacokinetics and in vitro reductive metabolism of acetohexamide in Wistar-Imamichi rats. (1999) (2)
Factors affecting acetohexamide reductase activities in microsomes and cytosol from the kidney of male rats: age and castration. (1992) (2)
Conjugation of Succinylated Gelatin to Soybean Trypsin Inhibitor (1996) (2)
Interaction of Protizinic Acid with Human Serum Albumin: Site-to-Site Displacement of Protizinic Acid by Ibuprofen (2017) (2)
Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin (2020) (2)
Processing grapefruit juice with γ‐cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity (2019) (2)
Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in rats. (2002) (2)
Interaction of Fluorescent Probe 7-Anilino-4-methylcoumarin-3-(p)-benzoic Acid with Egg Albumin. (1997) (2)
Future aspects of biomedical applications of chitin and chitosan in diseases associated with oxidative stress (2020) (2)
Enhanced Bioavailability of Digitalis Glycoside by Cyclodextrin Complexation (1982) (2)
An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. (2021) (2)
Catalytic Properties of Carbonyl Reductase from Rabbit Kidney for Acetohexamide and Its Analogs (1994) (2)
Carbonyl reductase purified from rabbit liver is not the product of a carbonyl reductase gene (RCBR5 or RCBR6) cloned from the rabbit liver cDNA library. (1998) (2)
Evaluation of low-molecular gelatin as a pharmaceutical additive for rapidly absorbed oral dosage formulation. (1991) (2)
Cadmium exposure decreases androgen-dependent metabolism of acetohexamide in liver microsomes of male rats through its testicular toxicity (2002) (2)
Glycative and oxidative modification of human serum albumin: Conformational and functional changes (2015) (2)
20 b-Hydroxysteroid Dehydrogenase Catalyzes Ketone-Reduction of Acetohexamide , an Oral Antidiabetic Drug , in Liver Microsomes of Adult Male Rats (1998) (2)
Interactions of Linezolid with Two Major Serum Proteins , Human Serum Albumin and Alpha-1 Acid Glycoprotein (2015) (2)
Sacran, a High-molecular Weight Polysaccharide Inhibits Renal Injury and Oxidative Stress in Chronic Renal Failure Model Rats (2018) (1)
Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique. (2020) (1)
A Safety Evaluation Study in Mice Revealed that Albumin Dimer is Safe for Medical and Pharmaceutical Applications (2020) (1)
In vivo evaluation of drug dialyzability in a rat model of hemodialysis (2020) (1)
Fluorescent investigations of binding of phenprocoumon to alpha 1-acid glycoprotein. (1987) (1)
Hypoglycemic action and disposition of gliclazide in normal and analbuminemic rats. (1990) (1)
Interaction between 7-anilino-4-methylcoumarin-3-acetic acid and human serum albumin. (1987) (1)
The effect of heptakis (2,6-di-O-methyl)-γ-cyclodextrin on mitomycin C stability in aqueous solution (1990) (1)
Studies of the Coordination Bonding and Stability of the Mixed-ligand Complexes of Copper(II) (1971) (1)
Differential hormonal regulation of carbonyl reductase activities in liver and kidney microsomes of rat (2002) (1)
Reactivity for prostaglandins and inhibition by nonsteridal anti-inflammatory drugs of rabbit liver befunolol reductase. (1991) (1)
Effect of cyclodextrins on anthracycline stability in acidic aqueous media (1988) (1)
S -nitrosated (cid:1) -1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis (2012) (1)
Pharmacokinetic Properties of Single and Repeated Injection of Liposomal Platelet Substitute in a Rat Model of Red Blood Cell Transfusion-Induced Dilutional Thrombocytopenia. (2015) (1)
Kinetics of befunolol reductase from rabbit liver. (1990) (1)
Inactivation of Rabbit Liver Carbonyl Reductase by Phenylglyoxal and 2,3,4-Trinitrobenzenesulfonate Sodium (2003) (1)
The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats. (2022) (1)
Influence of aging on acetohexamide reductase activities in liver microsomes and cytosol of male rats. (1994) (1)
Chemical modification of histidine residue in substrate-binding domain of carbonyl reductase from rabbit kidney. (1993) (1)
Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats. (2020) (1)
Potentialization mechanism of domino displacement on 123I-IMP serum protein binding (2001) (1)
Catalytic properties of carbonyl reductase from rabbit liver for analogs of acetohexamide and 4-acetylpyridine. (1994) (1)
IMPROVEMENTS OF SOME PHARMACEUTICAL CHARACTERISTICS OF VARIOUS STEROIDAL DRUGS BY CYCLODEXTRIN COMPLEXATION (1982) (1)
The effect of fatty acids and sodium doecyl sulfate on the induced optical activity of sulfaethidole - BSA complexes. (1976) (1)
Individual variation of acetohexamide reductase activities in liver microsomes and cytosol of rats. (1997) (1)
S-Nitroso Adducts of Albumin Analogs: Characterization, Categorization, and Possible Future Therapeutic Applications (2016) (1)
WITHDRAWN: S-nitrosated human serum albumin dimer as novel nano EPR enhancer applied to nano-anticancer drugs (2015) (1)
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH (2021) (1)
Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations. (1987) (1)
Effect of phenylbutazone on serum protein binding and disposition of sulfadimethoxine in human and rabbit (1988) (1)
Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant in Vitro Antioxidative Capacity Compared to the Wild-Type. (2017) (1)
[Effect of probenecid on plasma concentration and tissue distribution of sulfadimethoxine in fast and slow acetylator rabbits]. (1988) (1)
[Strain-, sex- and species-related differences of acetohexamide reductase and 20 beta-hydroxysteroid dehydrogenase activities in liver microsomes of experimental animals]. (2001) (1)
Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state. (1993) (1)
Investigation of Binding of Drugs with Natural Polymer Supplements (2005) (1)
The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases. (2021) (1)
[Effect of various drugs on the in vitro metabolic reduction of acetohexamide]. (1988) (1)
Preparation and Evaluation of a Suppository Dosage Form Containing Omeprazole (1997) (1)
Effects of oxidation on functional systems of human serum albumin (2001) (1)
Inhibitory effect of drugs with a ketone group on reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. (1997) (1)
Combined testosterone treatment in pubertal and adult periods induces male-specific acetohexamide reductase activity in liver microsomes of female rats. (1994) (1)
Effects of alpha(1)-acid glycoprotein on isometric tension of mouse aorta. (2003) (1)
A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease (2022) (1)
Toxicodynamic Evaluation of a Cisplatin–Chondroitin Sulfate Complex Using a Perfused Kidney and Human Proximal Tubular Cells (2011) (1)
Effects of beta- and gamma-cyclodextrins on release of betamethasone from ointment bases. (1984) (0)
Simultaneous determination of befunolol and its major metabolite, dihydrobefunolol, in plasma by high performance liquid chromatography (1989) (0)
Agents favorisant l'absorption a travers des muqueuses (1999) (0)
Stereoselective Drug Delivery through Prodrug Approach (2004) (0)
CERULOPLASMIN CATALYZE OXIDATION OF NITRIC OXIDE (1998) (0)
Study of structural-chemistry of sodium 4-phenylbutyrate on its binding to serum albumin (2018) (0)
Non-steroidal anti-inflammatory drugs containing pharmaceutical preparations. (1988) (0)
COMPETITIVE DISPLACEMENT OF SERUM PROTEIN BINDING TO REGULATE PHARMACOKINETICS OF A CEREBRAL BLOOD FLOW RADIOPHARMACEUTICAL (2000) (0)
Oxidized albumin may induce renal tubular injury via CD36 (2006) (0)
Mouse "reduced in osteosclerosis" transporter (Roct) functions as an organic anion transporter 3 (mOAT3) and is localized at abluminal membrane of blood-brain barrier (2004) (0)
Novel pathway of post-translational modification of human serum albumin by hypochlorous acid (2005) (0)
Ligand binding selectivity on genetic variants of human α1-acid glycoprotein (2005) (0)
[Serum protein binding of carbutamide in normal and alloxan diabetic rabbits]. (1985) (0)
[Dissolution and absorption behavior of meclizine dihydrochloride from soft gelatin capsules]. (1989) (0)
Antioxidant activity of renin-angiotensin system inhibitors in vascular endothelial cells (2006) (0)
Aspects of Human Alpha-1 Acid Glycoprotein — Structure and Function (2013) (0)
Interaction of Fluorescent Probe 7- benzoic Acid with Egg Albumin (2006) (0)
Species specificity in combination of the drug with the serum albumin. (1998) (0)
Effectiveness and its Prediction of Charcoal Hemoperfusion Treatment in Drug Overdose: A Guideline Based on the Protein Binding Percentage of the Drug (2000) (0)
TOPOLOGY ANALYSIS OF DRUG BINDING SITES ON HUMAN SERUM ALBUMIN USING SITE-DIRECTED MUTAGENESIS (2000) (0)
Effect of Stoichiometry of Cisplatin—Alginate Complex on the Pharmacokinetics of Cisplatin (1996) (0)
Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin (2022) (0)
Crystal structure of the A variant of human alpha1-acid glycoprotein and chlorpromazine complex (2011) (0)
EFFECT OF REPEATED ADMINISTRATION OF PYRIDINOLCARBAMATE ON THE RENAL EXCRETION OF SOME DRUGS IN RABBITS (1986) (0)
[Effect of chloral hydrate on renal excretion of furosemide in rabbits]. (1987) (0)
Microsoft Word-42482512-file00.docx (2010) (0)
SPECIES DIFFERENCE IN PROTEIN BINDING DISPLACEMENT OF SULFADIMETHOXINE (1989) (0)
PROTECTIVE EFFECT OF S-NITROSYLATED HUMAN SERUM ALBUMINS TO ORGAN INJURY (2010) (0)
Abstracts of papers Pharmaceutical and biomedical analysis meeting (2005) (0)
29 D 17-5 29 D 18-1 EVALUATION OF GLYCOSYLATED-RECOMBINANT ALBUMIN AS A LIVER-SPECIFIC CARRIER (2006) (0)
A sustained release by use of alginates. (1989) (0)
Study of the inclusion complexes formed between 4-phenylbutyrate and α-, β- and γ-cyclodextrin in solution and evaluation on their taste-masking properties. (2022) (0)
STRUCTURAL CHANGES AFFECT PHARMACOKINETICS OF HUMAN SERUM ALBUMIN (2006) (0)
Hemoglobin vesicles, PEGylated liposomes developed as a red blood substitute, do not induce the accelerated blood clearance phenomenon in mice (2009) (0)
Reduction in the local toxicity of chlorpromazine and its photoproducts by cyclodextrin complexation (1984) (0)
Preparations pharmaceutiques renfermant des anti-inflammatoires non steroidiens (1988) (0)
Crystal structure of the A variant of human alpha1-acid glycoprotein and amitriptyline complex (2011) (0)
NEW SYNTHESIS OF 1,3-DIMETHYL-7-HYDROXYPYRROLO(3,2-D)PYRIMIDINE-2,4(1H,3H)-DIONES (9-HYDROXY-9-DEAZATHEOPHYLLINES) (1982) (0)
Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations. (1983) (0)
Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits. (1985) (0)
A POSSIBLE LINK OF ADVANCED GLYCATION END-PRODUCTS (AGE) TO DIABETIC VASCULAR COMPLICATIONS (2003) (0)
Withdrawn: Effect of phosphodiesterase 5 inhibitors on the anti-tumor activity of poly-s-nitrosated human serum albumin (2015) (0)
Human serum albumin complexed with aripiprazole (2018) (0)
Enantioselective oral bioavailability of 0-isovaleryl propranolol as a potential prodrug of propranolol. (1992) (0)
EFFECTS OF VARIOUS FACTORS ON METABOLIC REDUCTION OF ACETOHEXAMIDE (1987) (0)
JPET #56499 1 Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration (2003) (0)
Control of EPR effect by tumor-targeted NO donor via endogenous albumin transport system (2018) (0)
Abstracts of papers symposium disposition and delivery of peptide drugs (2005) (0)
Study on the Binding of Dicumarol to ƒ ¿ 1-Acid Glycoprotein Using Circular Dichroism Spectroscopy (2010) (0)
Effect of simultaneous administration of drugs on absorption and excretion. XVIII. Differential effects of oral and rectal administration of chloral hydrate on the gastrointestinal absorption of sulfisoxazole in rabbits. (1984) (0)
Pharmacokinetic Properties of Alpha1-Acid Glycoprotein (2004) (0)
Study on Binding of Drug to Serum Protein (2009) (0)
PEPTIDE MOIETIES OF HUMAN ALPHA1-ACID GLYCOPROTEIN ARE INVOLVED IN LIGAND-BINDING PROPERTIES (2008) (0)
Interaction of Acetohexamide with Probenecid in Rabbits (1987) (0)
GS 025 Design of albumin-encapsulated liposomes and its pharmaceutical application (2018) (0)
Effects of arterial hemorrhage speed on the blood coagulation/fibrinolysis system and hemodynamics in rats. (2020) (0)
P081. Hepatic targeting system of S-nitrosylated human serum albumin enhanced by endogenous ligands binding (2006) (0)
[Displacing effect of serum protein binding on intestinal absorption of sulfadimethoxine]. (1989) (0)
REDUCTION OF INDICES OF OXIDATIVE STRESS IN NORMAL SUBJECTS BY CHITOSAN SUPPLEMENTS (2008) (0)
Interaction of Drug with Serum Albumin (1998) (0)
CLINICAL APPLICABILITY OF THIOREDOXIN-ALBUMIN FUSION PROTEIN FOR OXIDATIVE STRESS RELATED DISEASES (2016) (0)
Influence of Stereoselective Hydrolysis on Stereoselective Penetration of O‐Acetyl‐ and O‐Cyclohexanoylpropranolol Through Hairless Mouse Skin (1995) (0)
PREDICTION OF THE EFFECTIVENESS OF CHARCOAL HEMOPERFUSION TREATMENT IN DRUG OVERDOSE : A GUIDELINE BASED ON THE PROTEIN BINDING PERCENTAGE AND DISTRIBUTION VOLUME OF THE DRUG (1999) (0)
Crystal structure of the A variant of human alpha1-acid glycoprotein (2011) (0)
Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease. (2020) (0)
Hepatic targeting of S-nitrosylated human serum albumin enhanced by endogenous ligands binding (2006) (0)
WITHDRAWN: Suppression of ABCG2 expression by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism (2015) (0)
Letter: Circular dichroism study on inclusion complexes of beta-cyclodextrin with anti-inflammatory fanamates. (1974) (0)
Bioavailability of Suppository Containing Omeprazole in Healthy Volunteers and Hemorrhagic Ulcer Patients (1997) (0)
Hepatic cytochrome P450 profiles in hemorrhagic shock model rats after transfusion with stored red blood cells. (2020) (0)
Physicochemical and Pharmacokinetic Properties of Aprotinin–Polymer Conjugates in Mice (1998) (0)
Carbon Monoxide-bound Hemoglobin Vesicles: Current Facts and Potential Medical Applications (2021) (0)
QUANTITATIVE ANALYSIS OF DRUG-PROTEIN INTERACTION IN RENAL DISEASE STATE AND A DOSAGE PLAN USING DISPLACEMENT OF PROTEIN BINDING (2000) (0)
Stereoselective protein binding of ketoprofen in uremic serum: Effects of hemodialysis. (1992) (0)
Preparation a liberation freinee preparee grace a l'utilisation d'alginates (1989) (0)
SYNTHESES AND PROPERTIES OF 3-HYDROXY-4,6-DIMETHYLPYRROLO(3,2-D)PYRIMIDINE-5,7(4H,6H)-DIONE (9-HYDROXY-9-DEAZATHEOPHYLLINE) DERIVATIVES (1983) (0)
Sulfadimethoxine — bucolome interaction in rabbits : role of N4-acetylsulfadimethoxine, a major metabolite of sulfadimethoxine (1987) (0)
Determination of pyridinolcarbamate and its metabolites in rabbit plasma and urine by liquid chromatography. (1986) (0)
Human serum albumin complexed with sodium 4-phenylbutyrate (2018) (0)
THE ROLE OF SERUM PROTEIN BINDING IN THE INTESTINAL ABSORPTION OF DRUGS (1985) (0)
Effect of Nitric Oxide in Transthyretin-Related Amyloidosis (2007) (0)
Interaction between salicylic acid and repeatedly administered pyridinolcarbamate in rabbits. (1987) (0)
Modification of human serum albumin with reactive aldehydes alters the antioxidant activity (2010) (0)
CHARACTERIZATION OF CARBONYL REDUCTASES PURIFIED FROM RABBIT LIVER, KIDNEY AND HEART AS DRUG-METABOLIZING ENZYME (1994) (0)
Studies of befunolol reductase from rabbit liver (1990) (0)
Potential use of human serum albumin as a drug delivery systems (2015) (0)
Investigation of Inorganic Phosphorus Content in Various Supplements, Chinese Medicine Taken by Patients on Dialysis (2018) (0)
A uremic toxin 3-carboxy-4-methyl-5-propyl-2-furanpropionate accumulates in proximal tubular cells and induces cell damage through increasing oxidative stress (2012) (0)
Nonsteroidal antientzuendungswirkstoffe pharmaceutical compositions containing them. (1988) (0)
Effect of Intake of Liquid Meals on Canine Gastric Motility (1995) (0)
Effect of Fatty Acids and Uremic Toxins on the Binding of Nateglinide, an Insulin Secretagogue, to Site II on Human Serum Albumin. (2022) (0)
Abstracts of Dutch doctoral theses (2005) (0)
SUN-153 ACCUMULATION OF ACETAMINOPHEN METABOLITES EXERTS KIDNEY PROTECTIVE EFFECT IN RENAL FAILURE RAT MODEL (2019) (0)
Structural Insights into Differences in Drug-binding Selectivity between Two Forms of Human 1 -Acid (2011) (0)
BPB Reports (2019) (0)
[Preparation of negamycin ointments. I. Possible utility of gel bases]. (1986) (0)
[Effects of salicylic acid and salicylamide on sulfisoxazole disposition in rabbits]. (1986) (0)
Microsoft Word-82519030-file00 (2009) (0)
Postnatal development of acetohexamide reductase activities in microsomes and cytosol of rat liver. (1991) (0)
Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis. (2021) (0)
Realization of an attractive healthy longevity society with nucleic acid medicine (2016) (0)
ENHANCED BIOAVAILABILITY OF DIGITALIS GLYCOSIDE (1982) (0)
Pharmacokinetically modified human serum albumin based therapeutic design and development (2015) (0)
MODEL ANALYSIS OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIOR OF DRUG FOLLOWING DISSOLUTION FROM COMPRESSED TABLET : IN THE CASES OF SULFONAMIDES AND β-CYCLODEXTRIN COMPLEXES (1983) (0)
Interaction between P-cresyl sulfate and indoxyl sulfate during body disposition can influence their serum free concentrations in chronic kidney disease (2012) (0)
Enhanced Dissolution of Poorly Water-Soluble Drugs by Water-Soluble Gelatin (1989) (0)
Human serum albumin complexed with octanoate and N-acetyl-L-methionine (2017) (0)
In vivo and in vitro binding of (-)-hydroxyhexamide, a major metabolite of acetohexamide, to rabbit serum. (1989) (0)
WITHDRAWN: Protective effect of 1,25-dihydroxyvitamin D3 on concanavalin A-induced mouse hepatitis (2015) (0)
Protective effects of cyclodextrins on the hemolysis induced with tranquilizing phenothiazines (1982) (0)
Slow-release pharmaceutical composition prepared with alginic acid (1989) (0)
[Strategy of Drug Development Based on the Bioactive Gas-carrying Capacity of Hemoglobin]. (2020) (0)
ROLE OF LUNG AND SMALL INTESTINE ON THE FIRST-PASS METABOLISM OF ESTER DERIVATIVES OF PROPRANOLOL (1997) (0)
Alteration of acetohexamide reductase activities in kidney microsomes and cytosol of cadmium-treated rats. (1998) (0)
Quantitative assessment of cysteinylated human serum albumin using ESI-TOF/MS and its clinical significance in chronic liver disease (2012) (0)
In Vitro and In Vivo Assessment of Atemoya Fruit (Annona atemoya) for Food–Drug Interactions (2021) (0)
IDENTIFICATION OF DRUG BINDING SITE ON PLASMA PROTEINS USING PHOTOAFFINITY LABELLING TECHNIQUE (2008) (0)
Structural Basis of the Change in the Interaction Between Mycophenolic Acid and Subdomain IIA of Human Serum Albumin During Renal Failure. (2022) (0)
RELATIONSHIP BETWEEN THE PHARMACOKINETIC PROPERTIES OF AGE-PROTEINS AND THEIR RATE OF MODIFICATION BY AGE (2008) (0)
The potential of a cross-linked human serum albumin dimer in diabetic rats as an augmenting agent for antidiabetic drugs (2015) (0)
Human serum albumin complexed with 3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid (CMPF) (2005) (0)
Design and in vivo evaluation of antiinflammatory flurbiprofen chimera drug to reduce gastric irritation. (1991) (0)
Analyses of the Amyloid Fibrils in Bovine Amyloidosis in Hokkaido District, Japan (2004) (0)
Sex-related differences of acetohexamide reductase activities in the liver and kidney of various mammalian species. (1993) (0)
WITHDRAWN: Microenvironmental analysis of binding site of sodium phenylbutyrate on human serum albumin (2015) (0)
Regulation of 123I-IMP cerebral accumulation by competitive displacement of serum protein binding (2001) (0)
WITHDRAWN: The effects of liposomal hemoglobin-based artificial oxygen carriers (hemoglobin-vesicles) and red blood cells resuscitation on transfusion-related acute lung injury in hemorrhagic shock model rats (2015) (0)
[Differential effect of sodium bicarbonate on disposition of sulfadimethoxine and sulfisoxazole in rabbits]. (1989) (0)
Extended release pharmaceutical composition prepared with alginic acid (1989) (0)
THE DETECTION OF ENDOGENOUS S-GUANYLATED HUMAN SERUM ALBUMIN. (2009) (0)
Cell-penetrating albumin enhances the sublingual delivery of antigens through macropinocytosis. (2022) (0)
INCLUSION COMPLEXATIONS OF FLURBIPROFEN WITH β-CYCLODEXTRIN AND TRI-O-METHYL-β-CYCLODEXTRIN (1984) (0)
Effect of Endogenous Substances on the Binding of Sodium 4- Phenylbutyrate to Human Serum Albumin (2018) (0)
The Nitrated Form of Nateglinide Induces Apoptosis in Human Pancreatic Cancer Cells Through a Caspase-dependent Mechanism (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masaki Otagiri?

Masaki Otagiri is affiliated with the following schools:

Masaki Otagiri's Academic­Influence.com Rankings

Masaki Otagiri's Degrees

Similar Degrees You Can Earn

Why Is Masaki Otagiri Influential?

Masaki Otagiri's Published Works

Published Works

What Schools Are Affiliated With Masaki Otagiri?

Masaki Otagiri's AcademicInfluence.com Rankings